Učitavanje...
Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis: A network meta‐analysis
BACKGROUND: Methotrexate is considered the preferred disease‐modifying anti‐rheumatic drug (DMARD) for the treatment of rheumatoid arthritis, but controversy exists on the additional benefits and harms of combining methotrexate with other DMARDs. OBJECTIVES: To compare methotrexate and methotrexate‐...
Spremljeno u:
| Izdano u: | Cochrane Database Syst Rev |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2016
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7087436/ https://ncbi.nlm.nih.gov/pubmed/27571502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010227.pub2 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|